CA2836575A1 - Commande d'un dispositif a eau par le biais d'une interface utilisateur de machine de dialyse - Google Patents
Commande d'un dispositif a eau par le biais d'une interface utilisateur de machine de dialyse Download PDFInfo
- Publication number
- CA2836575A1 CA2836575A1 CA2836575A CA2836575A CA2836575A1 CA 2836575 A1 CA2836575 A1 CA 2836575A1 CA 2836575 A CA2836575 A CA 2836575A CA 2836575 A CA2836575 A CA 2836575A CA 2836575 A1 CA2836575 A1 CA 2836575A1
- Authority
- CA
- Canada
- Prior art keywords
- home therapy
- water treatment
- treatment device
- home
- therapy machine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 432
- 238000000502 dialysis Methods 0.000 title description 59
- 238000011282 treatment Methods 0.000 claims abstract description 443
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 416
- 238000004891 communication Methods 0.000 claims abstract description 28
- 239000012530 fluid Substances 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims description 63
- 238000012360 testing method Methods 0.000 claims description 33
- 238000012546 transfer Methods 0.000 claims description 16
- 230000008859 change Effects 0.000 claims description 13
- 238000012508 change request Methods 0.000 claims description 10
- 230000006266 hibernation Effects 0.000 claims description 2
- 230000008569 process Effects 0.000 description 42
- 239000003795 chemical substances by application Substances 0.000 description 24
- 238000001631 haemodialysis Methods 0.000 description 22
- 230000000322 hemodialysis Effects 0.000 description 22
- 239000008213 purified water Substances 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 238000002203 pretreatment Methods 0.000 description 15
- 230000008901 benefit Effects 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 238000004659 sterilization and disinfection Methods 0.000 description 11
- 210000003200 peritoneal cavity Anatomy 0.000 description 10
- 238000012545 processing Methods 0.000 description 10
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 9
- 239000000460 chlorine Substances 0.000 description 9
- 229910052801 chlorine Inorganic materials 0.000 description 9
- 210000004379 membrane Anatomy 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- 239000003053 toxin Substances 0.000 description 9
- 231100000765 toxin Toxicity 0.000 description 9
- 108700012359 toxins Proteins 0.000 description 9
- 239000002699 waste material Substances 0.000 description 8
- 238000012356 Product development Methods 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000002615 hemofiltration Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 208000001647 Renal Insufficiency Diseases 0.000 description 4
- 239000000385 dialysis solution Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000012377 drug delivery Methods 0.000 description 4
- 201000006370 kidney failure Diseases 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- 241001633663 Iris pseudacorus Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000013439 planning Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012384 transportation and delivery Methods 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 230000009474 immediate action Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 238000011903 nutritional therapy Methods 0.000 description 2
- 238000011022 operating instruction Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 230000002618 waking effect Effects 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000003863 metallic catalyst Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000011045 prefiltration Methods 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000005227 renal system Anatomy 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000013024 troubleshooting Methods 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/1668—Details of containers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/40—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Primary Health Care (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/828,822 US10973968B2 (en) | 2008-02-14 | 2013-03-14 | Control of a water device via a dialysis machine user interface |
| US13/828,822 | 2013-03-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2836575A1 true CA2836575A1 (fr) | 2014-09-14 |
Family
ID=50031065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2836575A Pending CA2836575A1 (fr) | 2013-03-14 | 2013-12-12 | Commande d'un dispositif a eau par le biais d'une interface utilisateur de machine de dialyse |
Country Status (7)
| Country | Link |
|---|---|
| JP (4) | JP2014176610A (fr) |
| AU (6) | AU2013276966B2 (fr) |
| CA (1) | CA2836575A1 (fr) |
| DE (1) | DE102014204546A1 (fr) |
| FR (1) | FR3003174B1 (fr) |
| GB (1) | GB2512431B (fr) |
| MX (2) | MX365492B (fr) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022144245A1 (fr) * | 2020-12-29 | 2022-07-07 | Fresenius Medical Care Deutschland Gmbh | Dispositif pour l'affichage combiné de données relatives à des machines de traitement du sang et des appareils de traitement d'eau |
| US11424934B2 (en) | 2017-04-26 | 2022-08-23 | Fresenius Medical Care Holdings, Inc. | Securely distributing medical prescriptions |
| EP4302793A3 (fr) * | 2016-12-21 | 2024-03-20 | Baxter International Inc. | Système de distribution de fluide médical comprenant une mise à jour et une commande de machine à distance |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2836575A1 (fr) * | 2013-03-14 | 2014-09-14 | Baxter International Inc. | Commande d'un dispositif a eau par le biais d'une interface utilisateur de machine de dialyse |
| EP3018601B1 (fr) | 2014-11-10 | 2021-06-23 | B. Braun Avitum AG | Procédé de dispositif de purification du sang |
| JP2017113424A (ja) * | 2015-12-25 | 2017-06-29 | 日本ウォーターシステム株式会社 | 透析システム |
| US11389575B2 (en) | 2017-07-14 | 2022-07-19 | Fresenius Medical Care Holdings, Inc. | Prescription compatibility checking for a medical device |
| US11185735B2 (en) | 2019-03-11 | 2021-11-30 | Rom Technologies, Inc. | System, method and apparatus for adjustable pedal crank |
| US11904202B2 (en) | 2019-03-11 | 2024-02-20 | Rom Technolgies, Inc. | Monitoring joint extension and flexion using a sensor device securable to an upper and lower limb |
| US11957960B2 (en) | 2019-05-10 | 2024-04-16 | Rehab2Fit Technologies Inc. | Method and system for using artificial intelligence to adjust pedal resistance |
| US12102878B2 (en) | 2019-05-10 | 2024-10-01 | Rehab2Fit Technologies, Inc. | Method and system for using artificial intelligence to determine a user's progress during interval training |
| US11801423B2 (en) | 2019-05-10 | 2023-10-31 | Rehab2Fit Technologies, Inc. | Method and system for using artificial intelligence to interact with a user of an exercise device during an exercise session |
| US11433276B2 (en) | 2019-05-10 | 2022-09-06 | Rehab2Fit Technologies, Inc. | Method and system for using artificial intelligence to independently adjust resistance of pedals based on leg strength |
| US11904207B2 (en) | 2019-05-10 | 2024-02-20 | Rehab2Fit Technologies, Inc. | Method and system for using artificial intelligence to present a user interface representing a user's progress in various domains |
| US11957956B2 (en) | 2019-05-10 | 2024-04-16 | Rehab2Fit Technologies, Inc. | System, method and apparatus for rehabilitation and exercise |
| US11833393B2 (en) | 2019-05-15 | 2023-12-05 | Rehab2Fit Technologies, Inc. | System and method for using an exercise machine to improve completion of an exercise |
| US11801419B2 (en) | 2019-05-23 | 2023-10-31 | Rehab2Fit Technologies, Inc. | System, method and apparatus for rehabilitation and exercise with multi-configurable accessories |
| US11896540B2 (en) | 2019-06-24 | 2024-02-13 | Rehab2Fit Technologies, Inc. | Method and system for implementing an exercise protocol for osteogenesis and/or muscular hypertrophy |
| US11701548B2 (en) * | 2019-10-07 | 2023-07-18 | Rom Technologies, Inc. | Computer-implemented questionnaire for orthopedic treatment |
| US11071597B2 (en) | 2019-10-03 | 2021-07-27 | Rom Technologies, Inc. | Telemedicine for orthopedic treatment |
| US11075000B2 (en) | 2019-10-03 | 2021-07-27 | Rom Technologies, Inc. | Method and system for using virtual avatars associated with medical professionals during exercise sessions |
| US11961603B2 (en) | 2019-10-03 | 2024-04-16 | Rom Technologies, Inc. | System and method for using AI ML and telemedicine to perform bariatric rehabilitation via an electromechanical machine |
| US11923065B2 (en) | 2019-10-03 | 2024-03-05 | Rom Technologies, Inc. | Systems and methods for using artificial intelligence and machine learning to detect abnormal heart rhythms of a user performing a treatment plan with an electromechanical machine |
| US11978559B2 (en) | 2019-10-03 | 2024-05-07 | Rom Technologies, Inc. | Systems and methods for remotely-enabled identification of a user infection |
| US11955223B2 (en) | 2019-10-03 | 2024-04-09 | Rom Technologies, Inc. | System and method for using artificial intelligence and machine learning to provide an enhanced user interface presenting data pertaining to cardiac health, bariatric health, pulmonary health, and/or cardio-oncologic health for the purpose of performing preventative actions |
| US11915816B2 (en) | 2019-10-03 | 2024-02-27 | Rom Technologies, Inc. | Systems and methods of using artificial intelligence and machine learning in a telemedical environment to predict user disease states |
| US12087426B2 (en) | 2019-10-03 | 2024-09-10 | Rom Technologies, Inc. | Systems and methods for using AI ML to predict, based on data analytics or big data, an optimal number or range of rehabilitation sessions for a user |
| US11887717B2 (en) | 2019-10-03 | 2024-01-30 | Rom Technologies, Inc. | System and method for using AI, machine learning and telemedicine to perform pulmonary rehabilitation via an electromechanical machine |
| US11317975B2 (en) | 2019-10-03 | 2022-05-03 | Rom Technologies, Inc. | Method and system for treating patients via telemedicine using sensor data from rehabilitation or exercise equipment |
| US11756666B2 (en) | 2019-10-03 | 2023-09-12 | Rom Technologies, Inc. | Systems and methods to enable communication detection between devices and performance of a preventative action |
| US11915815B2 (en) | 2019-10-03 | 2024-02-27 | Rom Technologies, Inc. | System and method for using artificial intelligence and machine learning and generic risk factors to improve cardiovascular health such that the need for additional cardiac interventions is mitigated |
| US12020800B2 (en) | 2019-10-03 | 2024-06-25 | Rom Technologies, Inc. | System and method for using AI/ML and telemedicine to integrate rehabilitation for a plurality of comorbid conditions |
| US11101028B2 (en) | 2019-10-03 | 2021-08-24 | Rom Technologies, Inc. | Method and system using artificial intelligence to monitor user characteristics during a telemedicine session |
| US11955222B2 (en) | 2019-10-03 | 2024-04-09 | Rom Technologies, Inc. | System and method for determining, based on advanced metrics of actual performance of an electromechanical machine, medical procedure eligibility in order to ascertain survivability rates and measures of quality-of-life criteria |
| US11955221B2 (en) | 2019-10-03 | 2024-04-09 | Rom Technologies, Inc. | System and method for using AI/ML to generate treatment plans to stimulate preferred angiogenesis |
| US12062425B2 (en) | 2019-10-03 | 2024-08-13 | Rom Technologies, Inc. | System and method for implementing a cardiac rehabilitation protocol by using artificial intelligence and standardized measurements |
| US11069436B2 (en) | 2019-10-03 | 2021-07-20 | Rom Technologies, Inc. | System and method for use of telemedicine-enabled rehabilitative hardware and for encouraging rehabilitative compliance through patient-based virtual shared sessions with patient-enabled mutual encouragement across simulated social networks |
| US11955220B2 (en) | 2019-10-03 | 2024-04-09 | Rom Technologies, Inc. | System and method for using AI/ML and telemedicine for invasive surgical treatment to determine a cardiac treatment plan that uses an electromechanical machine |
| US11830601B2 (en) | 2019-10-03 | 2023-11-28 | Rom Technologies, Inc. | System and method for facilitating cardiac rehabilitation among eligible users |
| US12020799B2 (en) | 2019-10-03 | 2024-06-25 | Rom Technologies, Inc. | Rowing machines, systems including rowing machines, and methods for using rowing machines to perform treatment plans for rehabilitation |
| US11826613B2 (en) | 2019-10-21 | 2023-11-28 | Rom Technologies, Inc. | Persuasive motivation for orthopedic treatment |
| CA3154829A1 (fr) * | 2019-11-05 | 2021-05-14 | Christy Elizabeth Garcia | Systeme d'administration de fluide medical comprenant une analytique de gestion de cooperation et d'observance de traitement de patient |
| US11107591B1 (en) | 2020-04-23 | 2021-08-31 | Rom Technologies, Inc. | Method and system for describing and recommending optimal treatment plans in adaptive telemedical or other contexts |
| US12100499B2 (en) | 2020-08-06 | 2024-09-24 | Rom Technologies, Inc. | Method and system for using artificial intelligence and machine learning to create optimal treatment plans based on monetary value amount generated and/or patient outcome |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5591344A (en) * | 1995-02-13 | 1997-01-07 | Aksys, Ltd. | Hot water disinfection of dialysis machines, including the extracorporeal circuit thereof |
| US5932110A (en) * | 1995-02-13 | 1999-08-03 | Aksys, Ltd. | Dialysate conductivity adjustment in a batch dialysate preparation system |
| US5624572A (en) * | 1995-06-07 | 1997-04-29 | Cobe Laboratories, Inc. | Power management system and method for maximizing heat delivered to dialysate in a dialysis machine |
| SE9901165D0 (sv) * | 1999-03-30 | 1999-03-30 | Gambro Lundia Ab | Method, apparatus and components of dialysis systems |
| US6229957B1 (en) * | 1999-05-14 | 2001-05-08 | Joseph Baker | Physiological fluid warming process and apparatus |
| DE19953837A1 (de) * | 1999-11-09 | 2001-05-23 | Fresenius Medical Care De Gmbh | Software-Update für ein medizinisches Gerät |
| JP2002172160A (ja) * | 2000-12-08 | 2002-06-18 | Nikkiso Co Ltd | 人工透析装置用水処理系 |
| US7153285B2 (en) * | 2002-01-17 | 2006-12-26 | Baxter International Inc. | Medical fluid heater using radiant energy |
| US7175606B2 (en) * | 2002-05-24 | 2007-02-13 | Baxter International Inc. | Disposable medical fluid unit having rigid frame |
| ATE434454T1 (de) * | 2003-01-07 | 2009-07-15 | Nxstage Medical Inc | Chargenfiltriersystem zur herstellung einer sterilen ersatzflüssigkeit für nierenbehandlungen |
| US20100137693A1 (en) * | 2005-11-01 | 2010-06-03 | Fresenius Medical Care Holdings, Inc. | Methods and systems for patient care |
| FR2896792B1 (fr) | 2006-01-27 | 2008-07-18 | Millipore Corp | Systeme et procede de purification d'eau |
| DE102006012198A1 (de) * | 2006-03-16 | 2007-09-27 | Seccua Gmbh | Steuerungen eines Filtrationssystems |
| JP5204995B2 (ja) * | 2006-06-22 | 2013-06-05 | 日機装株式会社 | 透析治療用セントラルシステム及びその消毒方法 |
| US20080045877A1 (en) * | 2006-08-15 | 2008-02-21 | G&L Consulting, Llc | Blood exchange dialysis method and apparatus |
| US8393690B2 (en) | 2007-02-27 | 2013-03-12 | Deka Products Limited Partnership | Enclosure for a portable hemodialysis system |
| US8562834B2 (en) | 2007-02-27 | 2013-10-22 | Deka Products Limited Partnership | Modular assembly for a portable hemodialysis system |
| US9415150B2 (en) | 2007-11-09 | 2016-08-16 | Baxter Healthcare S.A. | Balanced flow dialysis machine |
| US7892423B2 (en) | 2008-02-14 | 2011-02-22 | Baxter International Inc. | Dialysis system including multi-heater power coordination |
| US10973968B2 (en) * | 2008-02-14 | 2021-04-13 | Baxter International Inc. | Control of a water device via a dialysis machine user interface |
| US10089443B2 (en) * | 2012-05-15 | 2018-10-02 | Baxter International Inc. | Home medical device systems and methods for therapy prescription and tracking, servicing and inventory |
| US8057679B2 (en) * | 2008-07-09 | 2011-11-15 | Baxter International Inc. | Dialysis system having trending and alert generation |
| JP5425527B2 (ja) * | 2009-06-02 | 2014-02-26 | 三菱レイヨン・クリンスイ株式会社 | 透析システム |
| JP5423318B2 (ja) * | 2009-10-29 | 2014-02-19 | ニプロ株式会社 | 透析液の濃度監視装置およびその作動方法 |
| US20110189048A1 (en) * | 2009-12-05 | 2011-08-04 | Curtis James R | Modular dialysis system |
| US20120138533A1 (en) * | 2010-12-01 | 2012-06-07 | Curtis James R | Dialysis system control system with user interface |
| PL2684147T5 (pl) * | 2011-03-08 | 2023-02-20 | Gambro Lundia Ab | Sposób, moduł sterujący, urządzenie i układ do przenoszenia danych |
| AU2012230767A1 (en) * | 2011-03-23 | 2013-10-31 | Nxstage Medical, Inc. | Peritoneal dialysis systems, devices, and methods |
| CA2836575A1 (fr) * | 2013-03-14 | 2014-09-14 | Baxter International Inc. | Commande d'un dispositif a eau par le biais d'une interface utilisateur de machine de dialyse |
-
2013
- 2013-12-12 CA CA2836575A patent/CA2836575A1/fr active Pending
- 2013-12-12 JP JP2013257132A patent/JP2014176610A/ja active Pending
- 2013-12-17 GB GB201322331A patent/GB2512431B/en active Active
- 2013-12-24 AU AU2013276966A patent/AU2013276966B2/en active Active
-
2014
- 2014-02-07 MX MX2014001566A patent/MX365492B/es active IP Right Grant
- 2014-02-07 MX MX2019006526A patent/MX2019006526A/es unknown
- 2014-03-12 DE DE102014204546.0A patent/DE102014204546A1/de active Pending
- 2014-03-14 FR FR1452117A patent/FR3003174B1/fr active Active
-
2018
- 2018-12-07 AU AU2018274995A patent/AU2018274995B2/en active Active
- 2018-12-13 JP JP2018233707A patent/JP2019055282A/ja active Pending
-
2020
- 2020-06-16 AU AU2020204015A patent/AU2020204015B2/en active Active
-
2021
- 2021-01-22 JP JP2021008641A patent/JP2021072915A/ja active Pending
- 2021-04-14 AU AU2021202246A patent/AU2021202246B2/en active Active
- 2021-12-21 AU AU2021290244A patent/AU2021290244B2/en active Active
-
2022
- 2022-12-02 JP JP2022193339A patent/JP7546824B2/ja active Active
-
2023
- 2023-08-30 AU AU2023222880A patent/AU2023222880A1/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4302793A3 (fr) * | 2016-12-21 | 2024-03-20 | Baxter International Inc. | Système de distribution de fluide médical comprenant une mise à jour et une commande de machine à distance |
| US11424934B2 (en) | 2017-04-26 | 2022-08-23 | Fresenius Medical Care Holdings, Inc. | Securely distributing medical prescriptions |
| US12101414B2 (en) | 2017-04-26 | 2024-09-24 | Fresenius Medical Care Holdings, Inc. | Securely distributing medical prescriptions |
| WO2022144245A1 (fr) * | 2020-12-29 | 2022-07-07 | Fresenius Medical Care Deutschland Gmbh | Dispositif pour l'affichage combiné de données relatives à des machines de traitement du sang et des appareils de traitement d'eau |
Also Published As
| Publication number | Publication date |
|---|---|
| FR3003174B1 (fr) | 2021-06-04 |
| JP2014176610A (ja) | 2014-09-25 |
| FR3003174A1 (fr) | 2014-09-19 |
| AU2021202246B2 (en) | 2022-02-03 |
| AU2021290244A1 (en) | 2022-01-20 |
| MX2014001566A (es) | 2014-09-16 |
| AU2013276966A1 (en) | 2014-10-02 |
| GB2512431B (en) | 2015-05-13 |
| MX365492B (es) | 2019-06-05 |
| AU2018274995A1 (en) | 2019-01-03 |
| AU2020204015B2 (en) | 2021-05-06 |
| JP7546824B2 (ja) | 2024-09-09 |
| AU2023222880A1 (en) | 2023-09-14 |
| JP2021072915A (ja) | 2021-05-13 |
| GB201322331D0 (en) | 2014-01-29 |
| DE102014204546A1 (de) | 2014-11-06 |
| JP2023024494A (ja) | 2023-02-16 |
| JP2019055282A (ja) | 2019-04-11 |
| AU2018274995B2 (en) | 2020-03-19 |
| AU2013276966B2 (en) | 2018-12-20 |
| AU2021202246A1 (en) | 2021-05-06 |
| AU2021290244B2 (en) | 2023-06-01 |
| GB2512431A (en) | 2014-10-01 |
| MX2019006526A (es) | 2019-08-26 |
| AU2020204015A1 (en) | 2020-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2021290244B2 (en) | Control of a water device via a dialysis machine user interface | |
| US20220362446A1 (en) | Dialysis system including a water treatment device | |
| US11819596B2 (en) | Home renal therapy system and machine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20181211 |
|
| EEER | Examination request |
Effective date: 20181211 |
|
| EEER | Examination request |
Effective date: 20181211 |
|
| EEER | Examination request |
Effective date: 20181211 |
|
| EEER | Examination request |
Effective date: 20181211 |
|
| EEER | Examination request |
Effective date: 20181211 |
|
| EEER | Examination request |
Effective date: 20181211 |
|
| EEER | Examination request |
Effective date: 20181211 |
|
| EEER | Examination request |
Effective date: 20181211 |
|
| EEER | Examination request |
Effective date: 20181211 |
|
| EEER | Examination request |
Effective date: 20181211 |